ASHLEY HARRIS: Open Payments
NPI 1730671488 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 77 payments from 30 companies in 2025. Trend: 2023 $1,743 · 2024 $1,067 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $198 |
| GENZYME CORPORATION | 5 | $185 |
| Novartis Pharmaceuticals Corporation | 13 | $166 |
| AstraZeneca Pharmaceuticals LP | 7 | $163 |
| PFIZER INC. | 3 | $62 |
| Janssen Biotech, Inc. | 3 | $62 |
| Tempus AI, Inc | 2 | $59 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Dendreon Pharmaceuticals LLC | 2 | $47 |
Products named: Enhertu, WAYRILZ, DATROWAY, XT CDX, KEYTRUDA, SCEMBLIX, PROVENGE, SARCLISA.
Industry payments across FL — which companies pay providers there.
